Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma-Reference-Cited by-同舟云学术

Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma

Published:2014-11 Issue:11 Volume:8 Page:791-799
ISSN:1933-1711
Container-title:Journal of the American Society of Hypertension
language:en
Short-container-title:Journal of the American Society of Hypertension

Author:

Szmit Sebastian,Jurczak Wojciech,Zaucha Jan Maciej,Drozd-Sokołowska Joanna,Spychałowicz Wojciech,Joks Monika,Długosz-Danecka Monika,Torbicki Adam

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Reference40 articles.

1. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy;Felker;N Engl J Med,2000

2. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review;Kremer;Ann Oncol,2002

3. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk;Barrett-Lee;Ann Oncol,2009

4. Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study;Jurczak;Int J Cardiol,2013

5. Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines;Rigacci;Hematol Oncol,2007

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time course of hypertension and myocardial dysfunction following anthracycline chemotherapy in pediatric patients;IJC Heart & Vasculature;2024-08

2. Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients using¹⁸F-FDG positron emission tomography;2024-06-06

3. Hypertension Severity and Declines in Left Ventricular Ejection Fraction Among Women Receiving Adjuvant Chemotherapy for Breast Cancer (WF-97415 UPBEAT);Hypertension;2024-06

4. Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension—Real World Data of the Polish Lymphoma Research Group;Heart, Lung and Circulation;2024-05

5. Role of HDL cholesterol in anthracycline-induced subclinical cardiotoxicity: a prospective observational study in patients with diffuse large B-cell lymphoma treated with R-CHOP;BMJ Open;2024-02